Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Naoyuki Kuse

Showing results (21-30 of 52) with videos related to

Pageof 6
Sort By:
Internal Medicine (Tokyo, Japan)|February 4, 2020
Hemophagocytic Lymphohistiocytosis in a Patient with Rheumatoid Arthritis on Pembrolizumab for Lung AdenocarcinomaYu Akagi, Nobuyasu Awano, Minoru Inomata, et al.
Annals of Translational Medicine|May 13, 2020
Effectiveness and safety of benralizumab for severe asthma in clinical practice (J-BEST): a prospective studyTakehiro Izumo, Mari Tone, Naoyuki Kuse, et al.
Japanese Journal of Clinical Oncology|November 20, 2018
Nivolumab and stereotactic radiation therapy for the treatment of patients with Stage IV non-small-cell lung cancerShingo Miyamoto, Ryutaro Nomura, Kengo Sato, et al.
Thoracic Cancer|September 5, 2019
High mortality and poor treatment efficacy of immune checkpoint inhibitors in patients with severe grade checkpoint inhibitor pneumonitis in non-small cell lung cancerMari Tone, Takehiro Izumo, Nobuyasu Awano, et al.
ERJ Open Research|July 1, 2021
Body mass index and in-hospital mortality in patients with acute exacerbation of idiopathic pulmonary fibrosisNobuyasu Awano, Taisuke Jo, Hideo Yasunaga, et al.
Respiratory Medicine Case Reports|May 7, 2020
Rapid and sustained effects of a single dose of benralizumab on chronic eosinophilic pneumoniaTakehiro Izumo, Naoyuki Kuse, Nobuyasu Awano, et al.
Respiratory Investigation|September 1, 2020
Serum KL-6 level is a useful biomarker for evaluating the severity of coronavirus disease 2019Nobuyasu Awano, Minoru Inomata, Naoyuki Kuse, et al.
Drug Discoveries & Therapeutics|June 26, 2022
Efficacy and safety of sotrovimab for vaccinated or unvaccinated patients with mild-to-moderate COVID-19 in the omicron eraTakehiro Izumo, Nobuyasu Awano, Naoyuki Kuse, et al.
Respiratory Investigation|February 13, 2019
Management and utility of transbronchial lung cryobiopsy in JapanNaoyuki Kuse, Minoru Inomata, Nobuyasu Awano, et al.
Internal Medicine (Tokyo, Japan)|February 4, 2020
Anti-MDA5 Antibody-positive Clinically Amyopathic Dermatomyositis Complicated by Unilateral Right-sided Interstitial Lung DiseaseMayuko Kori, Nobuyasu Awano, Minoru Inomata, et al.
Pageof 6

Showing results (21-30 of 52) with videos related to

Sort By:
Pageof 6
Internal Medicine (Tokyo, Japan)|February 4, 2020
Hemophagocytic Lymphohistiocytosis in a Patient with Rheumatoid Arthritis on Pembrolizumab for Lung AdenocarcinomaYu Akagi, Nobuyasu Awano, Minoru Inomata, et al.
Annals of Translational Medicine|May 13, 2020
Effectiveness and safety of benralizumab for severe asthma in clinical practice (J-BEST): a prospective studyTakehiro Izumo, Mari Tone, Naoyuki Kuse, et al.
Japanese Journal of Clinical Oncology|November 20, 2018
Nivolumab and stereotactic radiation therapy for the treatment of patients with Stage IV non-small-cell lung cancerShingo Miyamoto, Ryutaro Nomura, Kengo Sato, et al.
Thoracic Cancer|September 5, 2019
High mortality and poor treatment efficacy of immune checkpoint inhibitors in patients with severe grade checkpoint inhibitor pneumonitis in non-small cell lung cancerMari Tone, Takehiro Izumo, Nobuyasu Awano, et al.
ERJ Open Research|July 1, 2021
Body mass index and in-hospital mortality in patients with acute exacerbation of idiopathic pulmonary fibrosisNobuyasu Awano, Taisuke Jo, Hideo Yasunaga, et al.
Respiratory Medicine Case Reports|May 7, 2020
Rapid and sustained effects of a single dose of benralizumab on chronic eosinophilic pneumoniaTakehiro Izumo, Naoyuki Kuse, Nobuyasu Awano, et al.
Respiratory Investigation|September 1, 2020
Serum KL-6 level is a useful biomarker for evaluating the severity of coronavirus disease 2019Nobuyasu Awano, Minoru Inomata, Naoyuki Kuse, et al.
Drug Discoveries & Therapeutics|June 26, 2022
Efficacy and safety of sotrovimab for vaccinated or unvaccinated patients with mild-to-moderate COVID-19 in the omicron eraTakehiro Izumo, Nobuyasu Awano, Naoyuki Kuse, et al.
Respiratory Investigation|February 13, 2019
Management and utility of transbronchial lung cryobiopsy in JapanNaoyuki Kuse, Minoru Inomata, Nobuyasu Awano, et al.
Internal Medicine (Tokyo, Japan)|February 4, 2020
Anti-MDA5 Antibody-positive Clinically Amyopathic Dermatomyositis Complicated by Unilateral Right-sided Interstitial Lung DiseaseMayuko Kori, Nobuyasu Awano, Minoru Inomata, et al.
Pageof 6